Long-Term Glycemic Control in Type 2 Diabetes – Key Points
Long-Term Glycemic Control in Type 2 Diabetes – Key Points
Source : Medscape 9 March, 2026
• The most accurate statement: Glycemic control reduces the risk of diabetes-related microvascular complications (chosen by 81% of respondents).
• Elevated blood glucose is strongly associated with microvascular complications such as retinopathy, nephropathy, and neuropathy.
• According to the American Diabetes Association (ADA), improving long-term glycemic control lowers the risk of these complications.
• Glycemic management does not replace cardiovascular risk management; diabetes care must also address lipids, blood pressure, and lifestyle factors.
• ADA guidance suggests optimizing glycemic management when triglycerides ≥150 mg/dL or HDL is low (<50 mg/dL in women, <40 mg/dL in men).
• LDL-C target (ADA Standards of Care):
– <70 mg/dL for adults with diabetes at high cardiovascular risk(2 1RF, or DM <10yrs)
– <55 mg/dL for patients with established ASCVD or very high risk(BM with multiple RF, DM<10yrs or with vascular disease) or <40 in poly vascular disease.